BUSINESSNEXT accelerates autonomous banking processes at Global Banks 19-01-2024, 12:30

Mobile Printer Market Size Projected To Reach USD 1.7 8-03-2023, 14:55

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00